Search This Blog

Thursday, February 28, 2019

Amneal Pharmaceuticals sees FY19 adjusted EPS 94c-$1.04, consensus $1.24

Sees FY19: adjusted EBITDA $600M-$650M; CapEx approximately $100M; adjusted effective tax rate 19%-21%; adjusted gross margin 47%-50%.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)